Product logins

Find logins to all Clarivate products below.


Mansoor Mukadam

Director, Commercial Strategy

Mansoor is a management consultant with 15 years of experience in Life sciences and Technology sector. Mansoor specializes in areas of Commercial strategy including Opportunity assessment, Geo-expansion and launch planning, M&A support, Forecasting, Tender planning and assessment. His experience spans across JAPAC, Middle East and Established markets.

Previously, Mansoor was an Associate Principal at IMS Consulting group, where he led various Commercial strategy projects in Geo-expansion, Go-to-Market planning, Commercial Due diligence, Policy strategy and Tender optimization. Mansoor also led engagements at PRTM and ZS Associates, where he advised several MNCs on Operations and Commercialization aspects such as Supply chain optimization, Manufacturing ad demand planning, CMC development, Go-to-market strategy, Customer Segmentation, Resource allocation and Goal setting. Besides consulting, Mansoor also held strategic roles in industry, where he managed Corporate strategy and M&A initiatives.

Throughout his career, Mansoor has developed a strong interest in product commercialization planning. He has actively engaged in thought leadership and developed whitepapers on key aspects of commercialization. Mansoor holds an MBA from the Indian School of Business, Hyderabad, and a B.Tech from National Institute of Technology, Trichy in India.


arrow_forward
Get in touch with Mansoor

Related resources

支付方愿意为便利性买单的市场准入“最佳切入点” 支付方愿意为便利性买单的市场准入“最佳切入点”
Blog June 3, 2026
支付方愿意为便利性买单的市场准入“最佳切入点”
医疗保险 定价 市场准入 真实世界数据 美国市场 药政法规
2026 年值得关注的 5 大医疗技术趋势 2026 年值得关注的 5 大医疗技术趋势
Blog May 28, 2026
2026 年值得关注的 5 大医疗技术趋势
AI/机器学习 GLP-1 医疗技术 带量采购(VBP) 日间手术中心(ASC)
《2026年最值得关注的药物》问答:礼来的下一代减肥药 《2026年最值得关注的药物》问答:礼来的下一代减肥药
Blog March 26, 2026
《2026年最值得关注的药物》问答:礼来的下一代减肥药
GLP-1 最值得关注的药物
为何长寿研究可能成为生物制药的下一个风口:当科学与商业的交汇 为何长寿研究可能成为生物制药的下一个风口:当科学与商业的交汇
Blog March 2, 2026
为何长寿研究可能成为生物制药的下一个风口:当科学与商业的交汇
AI/机器学习 GLP-1 临床试验 交易 药政法规 衰老生物学